ArticleResearch square2026
Choosing Among Randomized Design Families for Implementation Strategy Trials: A Question-Driven Framework with Practical Tools and Exemplars.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Background: Implementation science increasingly tests implementation strategies as interventions in their own right, but guidance for choosing among randomized design families remains dispersed across separate methodological literatures. Design selection can become method-driven rather than question-driven, producing trials that do not support the intended implementation decision. We developed a practical framework for selecting randomized designs when the implementation strategy, its components, rollout timing, or sequence is the randomized factor. Methods: We conducted a focused methodological synthesis updated through May 31, 2026. Because contemporaneous records of the initial exploratory search were unavailable, we conducted a structured verification search using domain-restricted queries targeting PubMed/PubMed Central records and publisher pages. Terms covered implementation strategies, cluster-randomized and stepped-wedge trials, factorial/MOST designs, SMARTs, and adaptive implementation. Sources were classified as completed trials, protocols, methods papers, or boundary examples. We compared design families by question, randomized factor, causal contrast, timing, data requirements, strengths, limitations, and feasibility. Results: Four complementary design families address four recurring decisions. Parallel and multi-arm cluster-randomized trials compare static implementation strategies. Stepped-wedge cluster-randomized trials evaluate randomized, staged rollout when timing can be assigned, and all clusters are expected to receive the strategy. Factorial experiments within the Multiphase Optimization Strategy identify active, redundant, or interacting components of multicomponent strategies. Sequential multiple assignment randomized trials develop adaptive sequences by re-randomizing sites or providers according to a prespecified intermediate response. The framework is operationalized through a five-step planning sequence, a question-to-design matrix, four design schematics, a worked cluster-trial power sensitivity analysis, and feasibility checks for factorial and adaptive trials. Conclusions: Randomized implementation strategy trials should begin with the decision the study must support: comparison, rollout, optimization, or adaptation-rather than a preferred method. Explicitly matching that question to the randomized factor, estimand, operational constraints, and realistic sample size, while treating cluster randomized trials, stepped-wedge designs, MOST/factorial designs, and SMARTs as complementary options within a unified framework, can improve rigor, efficiency, and interpretability and clarify when a simpler design is preferable. The accompanying tools provide practical guidance for investigators, implementation scientists, trialists, biostatisticians, funders, and research design cores, including CTSA-supported design and biostatistics cores. Contributions to the literature: Existing guides often describe individual trial designs but provide limited help choosing among randomized designs when an implementation strategy itself is assigned.This paper organizes four design families around the decision the trial must support: comparison, rollout, component optimization, or adaptation.Published trials and protocols illustrate how the randomized factor, unit of assignment, timing, and causal contrast differ across designs.A planning sequence, comparative table, design schematics, and worked feasibility calculations help teams justify design choices and identify when a simpler design is preferable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.